SCROLL DOWN
Next event
19 August
2025
Publication Half-Year Results 2025
24 March
2026
Publication Annual Results 2025
07 May
2026
Annual General Meeting 2026
Why invest in SKAN?
-
Market Leader
Undisputed market leader globally for high-end aseptic process solutions catering the global biopharma industry
-
Technology and innovation
Technology and innovation leadership with first-to-market solutions and reference point for aseptic manufacturing guidelines
-
Rapidly growing niche market
Strategically positioned in a highly dynamic and rapidly growing niche market driven by strong underlying end market growth
-
Entry barriers
Significant barriers to entry due to regulatory requirements and mission criticality of aseptic processes
-
Blue-chip customer base
Trusted, long-term partner to a large, blue-chip customer base, including all major biopharma companies
-
Excellent financial profile
Excellent financial profile with demonstrated profitable above-market growth and long-term revenue visibility